Skip to content

Safety and Efficacy of Epidural Spinal Cord Stimulation in Patients with Limb Paralysis After Stroke or Traumatic Brain Injury

Safety and Efficacy of Epidural Spinal Cord Stimulation in Patients with Limb Paralysis After Stroke or Traumatic Brain Injury

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500103168
Enrollment
Unknown
Registered
2025-05-26
Start date
2025-05-28
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

intervention group:Epidural Spinal Cord Stimulation

Sponsors

Beijing Tiantan Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Age 18-80 years; 2) Ischemic stroke, hemorrhagic stroke, or traumatic brain injury causing limb paralysis occurring more than 3 months prior to enrollment, with stable vital signs and intracranial condition; 3) Presence or absence of impaired consciousness; 4) For conscious patients without significant limb muscle hypertonia: Upper limb FMA score 7, lower limb score 5; 5) For conscious patients without significant limb muscle hypertonia: Significant muscle strength reduction (not exceeding Grade 3 but >0) during movement in one or more joints of the affected limb; 6) For conscious or unconscious patients with significant limb muscle hypertonia, hyperreflexia, or muscle spasms: MAS score >= 2; 7) Informed consent obtained.

Exclusion criteria

Exclusion criteria: 1) Receiving anticoagulant, antispasmodic, antiepileptic, or similar medications during the entire study period; 2)Patients with impaired consciousness but no significant muscle hypertonia in the paralyzed limb (flaccid paralysis); 3) Presence of any medically implanted device in the body; 4) Any contraindications to spinal cord stimulation (SCS); 5) Suspected or confirmed pregnancy; 6) Inability to perform neurological function assessments; 7) Severe terminal illness or other serious medical conditions that may impair the ability to participate in the study; 8) Severe claustrophobia; 9) Researchers deem joint contractures too severe for study participation; 10) Other circumstances where researchers determine participation is not feasible; 11) Failure to obtain informed consent.

Design outcomes

Primary

MeasureTime frame
Modified Ashworth Scale, MAS;Muscle strength;Fugl-Meyer motor function assessment, FMA;Action Research Arm Test, ARAT;Composite Spasticity Scale, CSS;Coma Recovery Scale-Revised, CRS-R;

Countries

China

Contacts

Public ContactYi Yang

Beijing Tiantan Hospital Affiliated to Capital Medical University

yangyi_81nk@163.com+86 138 1096 0062

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026